Adropin and MOTS-c as new peptides: Do levels change in neurodegenerative diseases and ischemic stroke?
Hikmet SaçmaciMurat ÇakırSeda S ÖzcanPublished in: Journal of biochemical and molecular toxicology (2022)
This study provides new information about adropin may be potentially important markers in AD and MOTS-C in AIS and AD. Future studies are needed to examine the relationship between changes in metabolic profiles and these peptides.